Buckingham Research Upgrades The Andersons, Inc. (ANDE) to Buy
- Futures rise ahead of Trump's inauguration
- General Electric (GE) Reports In-Line Q4 EPS
- Procter & Gamble (PG) Tops Q2 EPS by 2c
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Dollar recoups losses, caution sets in ahead of Trump inauguration
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Buckingham Research upgraded The Andersons, Inc. (NASDAQ: ANDE) from Neutral to Buy.
The analyst said, "Conducive To Positive EPS Surprises"
Shares of The Andersons, Inc. closed at $34.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: SunTrust Robinson Humphrey Upgrades Brixmor Property (BRX) to Buy
- UPDATE: Ladenburg Thalmann Starts TC Pipelines (TCP) at Neutral
- Wedbush Assumes, Upgrades Visa (V) to Outperform
Create E-mail Alert Related CategoriesAnalyst Comments, Hot Upgrades, Upgrades
Related EntitiesBuckingham Research
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!